Related references
Note: Only part of the references are listed.A dynamic blood flow model to compute absorbed dose to circulating blood and lymphocytes in liver external beam radiotherapy
Shu Xing et al.
PHYSICS IN MEDICINE AND BIOLOGY (2022)
Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy
Yeona Cho et al.
RADIOTHERAPY AND ONCOLOGY (2022)
Proton therapy reduces the likelihood of high-grade radiation-induced lymphopenia in glioblastoma patients: phase II randomized study of protons vs photons
Radhe Mohan et al.
NEURO-ONCOLOGY (2021)
Four-Year Survival With Durvalumab After Chemoradiotherapy in Stage III NSCLC-an Update From the PACIFIC Trial
Corinne Faivre-Finn et al.
JOURNAL OF THORACIC ONCOLOGY (2021)
Radiation-induced lymphopenia during chemoradiation therapy for non-small cell lung cancer is linked with age, lung V5, and XRCC1 rs25487 genotypes in lymphocytes
Xiaoxue Xie et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Epidemiology of stage III lung cancer: frequency, diagnostic characteristics, and survival
Ana Casal-Mourino et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2021)
Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy
Nalee Kim et al.
RADIOTHERAPY AND ONCOLOGY (2021)
Association of severe lymphopenia and disease progression in unresectable locally advanced non-small cell lung cancer treated with definitive chemoradiation and immunotherapy
Cole Friedes et al.
LUNG CANCER (2021)
Risk and impact of radiation related lymphopenia in lung cancer: A systematic review and meta-analysis
Rituraj Upadhyay et al.
RADIOTHERAPY AND ONCOLOGY (2021)
The Influence of Severe Radiation-Induced Lymphopenia on Overall Survival in Solid Tumors: A Systematic Review and Meta-Analysis
Pim J. J. Damen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)
HEDOS-a computational tool to assess radiation dose to circulating blood cells during external beam radiotherapy based on whole-body blood flow simulations
Jungwook Shin et al.
PHYSICS IN MEDICINE AND BIOLOGY (2021)
Prediction of Severe Lymphopenia During Chemoradiation Therapy for Esophageal Cancer: Development and Validation of a Pretreatment Nomogram
Peter S. N. van Rossum et al.
PRACTICAL RADIATION ONCOLOGY (2020)
Absolute Lymphocyte Count Predicts Abscopal Responses and Outcomes in Patients Receiving Combined Immunotherapy and Radiation Therapy: Analysis of 3 Phase 1/2 Trials
Dawei Chen et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Prognosis and Risk Factors of Radiation-Induced Lymphopenia in Early-Stage Lung Cancer Treated With Stereotactic Body Radiation Therapy
Qianqian Zhao et al.
FRONTIERS IN ONCOLOGY (2020)
Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy
Philippe Lambin et al.
SEMINARS IN RADIATION ONCOLOGY (2020)
Radiotherapy-Related Lymphopenia Affects Overall Survival in Patients With Lung Cancer
Azadeh Abravan et al.
JOURNAL OF THORACIC ONCOLOGY (2020)
A tumor-immune interaction model for hepatocellular carcinoma based on measured lymphocyte counts in patients undergoing radiotherapy
Wonmo Sung et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy
Dawei Chen et al.
RADIOTHERAPY AND ONCOLOGY (2020)
Radiotherapy-related lymphopenia in patients with advanced non-small cell lung cancer receiving palliative radiotherapy
Azadeh Abravan et al.
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2020)
Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?
Christine Menetrier-Caux et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC
Qianqian Zhao et al.
RADIATION ONCOLOGY (2019)
Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation Therapy
Colton J. Ladbury et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Assessing the interactions between radiotherapy and antitumour immunity
Clemens Grassberger et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer
Yeona Cho et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Lymphopenia association with accelerated hyperfractionation and its effects on limited-stage small cell lung cancer patients' clinical outcomes
Xin Wang et al.
ANNALS OF TRANSLATIONAL MEDICINE (2019)
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
S. J. Antonia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Severe lymphopenia during neoadjuvant chemoradiation for esophageal cancer: A propensity matched analysis of the relative risk of proton versus photon-based radiation therapy
Yutaka Shiraishi et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors
Susannah G. Ellsworth
ADVANCES IN RADIATION ONCOLOGY (2018)
Does Unintentional Splenic Radiation Predict Outcomes After Pancreatic Cancer Radiation Therapy?
Awalpreet S. Chadha et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2017)
Relationships between lymphocyte counts and treatment-related toxicities and clinical responses in patients with solid tumors treated with PD-1 checkpoint inhibitors
Adam Diehl et al.
ONCOTARGET (2017)
Effects of Chemotherapy Regimen and Radiation Modality on Hematologic Toxicities in Patients Receiving Definitive Platinum-based Doublet Chemoradiation for Non-Small Cell Lung Cancer
Chad Tang et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2017)
Thoracic Vertebral Body Irradiation Contributes to Acute Hematologic Toxicity During Chemoradiation Therapy for Non-Small Cell Lung Cancer
Matthew P. Deek et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
TOTAL LYMPHOCYTE COUNT AND SERUM ALBUMIN AS PREDICTORS OF NUTRITIONAL RISK IN SURGICAL PATIENTS
Naruna Pereira Rocha et al.
ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY (2015)
Lymphopenia Association With Gross Tumor Volume and Lung V5 and Its Effects on Non-Small Cell Lung Cancer Patient Outcomes
Chad Tang et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2014)
Share Paper
